How Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence?
In noncompartmental analysis, poor characterization of the terminal elimination rate constant (Kel) will lead to biased results for half-life and total exposure (AUCinf), providing incorrect relative bioavailability and bioequivalence conclusions. We set out to determine if the sampling scheme durat...
Saved in:
Main Authors: | Philippe Colucci (Author), Jacques Turgeon (Author), Murray P. Ducharme (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rethinking bioequivalence and equivalence requirements of orally inhaled drug products
by: Dina Al-Numani, et al.
Published: (2015) -
Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations
by: Deniz Ozdin, et al.
Published: (2018) -
Influence of Different Populations on Pharmacokinetic Bioequivalence Results: Can We Extrapolate Bioequivalence Results from One Population to Another?
by: Deniz Ozdin, et al.
Published: (2020) -
When Bioequivalence in Healthy Volunteers May not Translate to Bioequivalence in Patients: Differential Effects of Increased Gastric pH on the Pharmacokinetics of Levothyroxine Capsules and Tablets
by: Corinne Seng Yue, et al.
Published: (2015) -
Novel Population Pharmacokinetic Method Compared to the Standard Noncompartmental Approach to Assess Bioequivalence of Iron Gluconate Formulations
by: Corinne Seng Yue, et al.
Published: (2013)